Friedman, Allan H.
Duke University Medical Center,
United States
2025 Rank: 32709
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2366 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32709 | 37940 |
| Total Cites | 40013 | 43361 |
| H-index | 91 | 95 |
| Hm-index | 27 | 28 |
| Number of Single Authored Papers | 22 | 22 |
| Total Cites to Single Authored Papers | 205 | 206 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 820 | 824 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 2494 | 2564 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 30978 | 32581 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.33 |
| Self-Citation Percentage |
7.72%
|
|
Friedman, Allan H.
Duke University School of Medicine,
United States
2024 Rank: 32197
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2377 out of 341636 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32197 | 36748 |
| Total Cites | 39309 | 42815 |
| H-index | 89 | 93 |
| Hm-index | 27 | 27 |
| Number of Single Authored Papers | 22 | 22 |
| Total Cites to Single Authored Papers | 187 | 188 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 786 | 790 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 2384 | 2451 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 30688 | 32461 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.32 |
| Self-Citation Percentage |
8.19%
|
|
Friedman, Allan H.
Duke Cancer Institute,
United States
2023 Rank: 31538
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2357 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31538 | 36199 |
| Total Cites | 37299 | 40721 |
| H-index | 87 | 91 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 22 | 22 |
| Total Cites to Single Authored Papers | 167 | 168 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 754 | 758 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 2269 | 2334 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 29027 | 30750 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.32 |
| Self-Citation Percentage |
8.40%
|
|
Friedman, Allan H.
Duke University Medical Center,
United States
2022 Rank: 30746
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2330 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30746 | 35684 |
| Total Cites | 34702 | 38016 |
| H-index | 84 | 89 |
| Hm-index | 25 | 25 |
| Number of Single Authored Papers | 22 | 22 |
| Total Cites to Single Authored Papers | 154 | 155 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 720 | 724 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 2134 | 2196 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 26937 | 28584 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.33 |
| Self-Citation Percentage |
8.72%
|
|
Friedman, Allan H.
Duke University Medical Center,
United States
2021 Rank: 31050
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2349 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31050 | 35617 |
| Total Cites | 32038 | 35043 |
| H-index | 82 | 86 |
| Hm-index | 25 | 25 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 151 | 152 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 691 | 695 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 2055 | 2113 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 24645 | 26032 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
8.58%
|
|
Friedman, Allan H.
Duke University,
United States
2020 Rank: 29313
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2302 out of 227881 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29313 | 34375 |
| Total Cites | 29309 | 32217 |
| H-index | 80 | 84 |
| Hm-index | 24 | 24 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 137 | 138 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 663 | 667 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 1940 | 1995 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 22458 | 23795 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.35 |
| Self-Citation Percentage |
9.03%
|
|